Education
About Us
Working with TipRanks
Follow Us
JB Chemicals & Pharmaceuticals Ltd. (IN:JBCHEPHARM)
:JBCHEPHARM
JBCHEPHARM Stock Chart & Stats
₹1847.80
-₹0.05(>-0.01%)
At close: 4:00 PM EST
₹1847.80
-₹0.05(>-0.01%)
Day’s Range― - ―
52-Week Range₹1,303.00 - ₹2,014.10
Previous CloseN/A
Volume153.25K
Average Volume (3M)2.67K
Market Cap
₹318.39B
Enterprise Value₹320.79B
Total Cash (Recent Filing)₹4.50B
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)41.1
Beta0.62
Next Earnings
May 21, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.86%
Share Statistics
EPS (TTM)12.70
Shares Outstanding160,527,540
10 Day Avg. Volume4,569
30 Day Avg. Volume2,671
Financial Highlights & Ratios
PEG Ratio1.96
Price to Book (P/B)7.17
Price to Sales (P/S)6.28
P/FCF Ratio30.57
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue Growth & MarginsMaterial multi-year revenue expansion alongside strong gross and improving net margins indicates the company is scaling core products profitably. That revenue and margin mix supports durable cash generation and reinvestment capacity across business cycles.
Balance Sheet StrengthLow leverage and a high equity proportion reduce refinancing and solvency risks, enabling the company to fund growth internally or via modest borrowing. This financial flexibility supports long-term R&D, commercial expansion and resilience to demand shocks.
Operating Cash GenerationConsistent operating cash conversion and rising free cash flow underpin sustainable capital allocation—funding capex, working capital and shareholder returns—while reducing reliance on external financing for medium-term strategic initiatives.
Bears Say
CapEx Volatility RiskVariable or lumpy capex can compress free cash flow unpredictably, forcing trade-offs between maintenance, growth investments and dividends. Over a 2–6 month horizon, uneven capex plans can weaken liquidity cushions and reduce funding flexibility for expansion.
Business ConcentrationHigh reliance on branded generics and domestic prescription channels concentrates revenue exposure to pricing pressure, reimbursement changes and local regulatory shifts. Limited diversification can magnify downside if key therapy areas or markets face structural headwinds.
Limited Investor CommunicationAbsence of regular earnings-call guidance and detailed investor dialogue reduces transparency into strategy, growth drivers and management priorities. For investors, this makes it harder to assess execution risk and long-term management accountability.
JB Chemicals & Pharmaceuticals Ltd. News
JBCHEPHARM FAQ
What was JB Chemicals & Pharmaceuticals Ltd.’s price range in the past 12 months?
JB Chemicals & Pharmaceuticals Ltd. lowest stock price was ₹1303.00 and its highest was ₹2014.10 in the past 12 months.
What is JB Chemicals & Pharmaceuticals Ltd.’s market cap?
JB Chemicals & Pharmaceuticals Ltd.’s market cap is ₹318.39B.
When is JB Chemicals & Pharmaceuticals Ltd.’s upcoming earnings report date?
JB Chemicals & Pharmaceuticals Ltd.’s upcoming earnings report date is May 21, 2026 which is in 88 days.
How were JB Chemicals & Pharmaceuticals Ltd.’s earnings last quarter?
JB Chemicals & Pharmaceuticals Ltd. released its earnings results on Jan 16, 2026. The company reported ₹12.7 earnings per share for the quarter, beating the consensus estimate of ₹12.3 by ₹0.4.
Is JB Chemicals & Pharmaceuticals Ltd. overvalued?
According to Wall Street analysts JB Chemicals & Pharmaceuticals Ltd.’s price is currently Overvalued.
Does JB Chemicals & Pharmaceuticals Ltd. pay dividends?
JB Chemicals & Pharmaceuticals Ltd. pays a Semiannually dividend of ₹7 which represents an annual dividend yield of 0.86%. See more information on JB Chemicals & Pharmaceuticals Ltd. dividends here
What is JB Chemicals & Pharmaceuticals Ltd.’s EPS estimate?
JB Chemicals & Pharmaceuticals Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does JB Chemicals & Pharmaceuticals Ltd. have?
JB Chemicals & Pharmaceuticals Ltd. has 160,527,540 shares outstanding.
What happened to JB Chemicals & Pharmaceuticals Ltd.’s price movement after its last earnings report?
JB Chemicals & Pharmaceuticals Ltd. reported an EPS of ₹12.7 in its last earnings report, beating expectations of ₹12.3. Following the earnings report the stock price went up 0.388%.
Which hedge fund is a major shareholder of JB Chemicals & Pharmaceuticals Ltd.?
Currently, no hedge funds are holding shares in IN:JBCHEPHARM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
JB Chemicals & Pharmaceuticals Ltd.
J. B. Chemicals & Pharmaceuticals Limited manufactures and markets various pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients in India and internationally. Its principal products include Cilnidipine, Ranitidine, and Metronidazole. The company also provides contract manufacturing services for tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, and capsules; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms. In addition, it offers a range of contrast media products, including x-ray, magnetic resonance imaging (MRI), and ultrasound scanners. Further, the company provides its services in gastroenterology, hypertension, diabetes, dermatology, nephrology, wound care, anti-infectives, and pharmacovigilance therapeutic areas. J. B. Chemicals & Pharmaceuticals Limited was incorporated in 1976 and is based in Mumbai, India.
Technical Analysis
Ajanta Pharma Limited
―
Emcure Pharmaceuticals Limited
―
Gland Pharma Ltd.
―
Glenmark Pharmaceuticals Limited
―
PFIZER LIMITED
―